CLINICAL THYROIDOLOGY FOR PATIENTS
A publication of the American Thyroid Association

Table of Contents

EDITOR’S COMMENTS

Welcome to Clinical Thyroidology for Patients. This publication is a collection of summaries of recently published articles from the medical literature that covers the broad spectrum of thyroid disorders. Clinical Thyroidology for Patients is published on a monthly basis and includes summaries of research studies that were discussed in the previous month’s issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. The Calendar of Events highlights educational forums and support groups that are organized by members of the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, the Graves’ Disease Foundation, the Light of Life Foundation and ThyCa: Thyroid Cancer Survivors Association.

IN THIS ISSUE, STUDIES ASK THE FOLLOWING QUESTIONS:

  • How effective of the new cancer drug, Sorafenib, in treating advanced, metastatic thyroid cancer?
  • Is the severe side effect of Methimazole-induced agranulocytosis dose-related?
  • What ultrasound features separate benign from cancerous thyroid nodules?
  • What are the risk factors for cancer recurrence in patients with papillary microcarcinoma?
  • What is the role of ultrasound-guided biopsy in the evaluation of thyroid nodules in children and adolescents?

We welcome your feedback and suggestions. Please follow this link to let us know what you want to see in this publication. I hope you find these summaries interesting and informative.

— Alan Farwell, MD